Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases. Wang, L., Voss, E. A., Weaver, J., Hester, L., Yuan, Z., DeFalco, F., Schuemie, M. J., Ryan, P. B., Sun, D., Freedman, A., Alba, M., Lind, J., Meininger, G., Berlin, J. A., & Rosenthal, N. Pharmacoepidemiol Drug Saf, 28(12):1620-1628, 2019.
doi  bibtex   
@article{RN213,
   author = {Wang, L. and Voss, E. A. and Weaver, J. and Hester, L. and Yuan, Z. and DeFalco, F. and Schuemie, M. J. and Ryan, P. B. and Sun, D. and Freedman, A. and Alba, M. and Lind, J. and Meininger, G. and Berlin, J. A. and Rosenthal, N.},
   title = {Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases},
   journal = {Pharmacoepidemiol Drug Saf},
   volume = {28},
   number = {12},
   pages = {1620-1628},
   ISSN = {1053-8569 (Print)
1053-8569},
   DOI = {10.1002/pds.4887},
   year = {2019},
   type = {Journal Article}
}

Downloads: 0